David H. Persing, Executive VP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 15,000 shares at $36.13 ($542K) on 2013-02-22, disclosed to the SEC on 2013-02-25.
Open-market sale of $542k CPHD by Executive VP, Chief Med/Tech Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CPHD | SELL | 2014-12-02 | $837K | — | Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |